Sébastien Jacquemont, Ph.D.
Sarah Lippé, Ph.D.
Baudouin Forgeot d’Arc, M.D. , Ph.D.
Sébastien Jacquemont is a medical geneticist and associate professor at the University hospital of St. Justine. He holds a Canadian research chair, a JJL Levesque chair in genetics of neuropsychiatric disorders as well as a Swiss national foundation assistant professorship. Sébastien was trained as a clinical geneticist and subsequently completed a research fellowship in developmental pediatrics at the MIND institute, UC Davis. His strong interest in translational research has led him to develop and conduct, in collaboration with other investigators some of the first targeted clinical trials in patients with Fragile X syndrome. Sébastien is also investigating the impact of gene dosage on neurodevelopment. His group is focused on how genetic variants lead to neuropsychiatric disorders using disease and general population cohorts.
Sarah Lippé is full Professor of Neuropsychology at University of Montreal, Fellow of the Fond de Recherche du Québec en Santé (FRQS), Deputy Head of the research axis Brain and Child Development at CHU Sainte-Justine Research Center, and scientist at CHU Sainte-Justine. Sarah has a PhD in Psychology from the University of Montréal (2006) and completed a postdoctoral fellowship at the Necker Enfants Malades, Atomic Energy Commission and Neurospin (2006-2009). She holds major grants from the Canadian Foundation for Innovation, The Canadian Institutes of Health Research, the Natural Science and Engineering Research Council of Canada, the Social Science Research Council of Canada, the Fonds de Recherche du Québec and the Kid’s Brain Health Network. Sarah studies risk factors and trajectories for neurodevelopmental disorders. She has developed biomarkers sensitive to brain maturation and cognitive development. She currently uses advanced imaging signal processing and modern statistics to delineate etiologic mechanisms leading to abnormal neurodevelopment. These findings lead to novel strategies in assessing outcomes in clinical trials and other intervention means aiming at improving cognition in children. Sarah is currently leading EEG phenotyping of two international clinical trials. Her laboratory infrastructure includes EEG, eye tracking, physiological measures, in addition to MEG and MRI access.
Baudouin Forgeot d'Arc (Associate Professor, Dept Psychiatry) is a researcher involved in the cognitive neuroscience of social interaction, and a child and adolescent psychiatrist with expertise in neurodevelopmental disorders. His experimental work contributes to defining the social profile of autism using behavioural studies, computational models and neuroimaging. Dr Forgeot d'Arc was trained in Paris in psychiatry (University Denis-Diderot), cognitive Science (MSc, PhD, École Normale Supérieure & Université Pierre-et-Marie-Curie) and completed a fellowship in child psychiatry (Hôpital Robert-Debré) before he moved to Hôpital Rivières-des-Prairies (2011) and CHU Ste-Justine (2018) where he leads the Integrated Center of the Child Neurodevelopment Network (CIRENE Centre Intégré du Réseau en Neurodéveloppement de l'Enfant). He also chairs the TACC (Transforming Autism Care Consortium) clinical committee.
Maryse Thibeault, BSc, RN, CCRP
Clinical Research Coordinator, CHU Sainte-Justine
Sophie Morin, RN, CCRP
Research Nurse, CHU Sainte-Justine, Coordinator for the project
Sylvie Pelletier, MEd
Psychoeducator, CHU Sainte-Justine
Charles-Olivier Martin, Ph.D.
Research coordinator in clinical neurosciences, CHU Sainte-Justine
Inga Sophia Knoth, M.Sc.
Research Coordinator, NED Laboratory, CHU Sainte-Justine